Fingerprint
Dive into the research topics of 'Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically